Sharing a post from Dr. Gary Gordon, emphasizing the importance of diagnosing and treating thyroid imbalances. At our office , we have found Thyroflex to be an excellent way to assess the functioning of the thyroid gland. We also test the blood for the active hormones and find that the results from our Thyroflex readings are more accurate and more valuable in terms of adequately treating thyroid imbalances. The result is that our patients feel more energy, are able to maintain their desired weight, and experience a stronger immune system and a more positive attitude.
Here’s to supporting your body’s ability to heal itself, and regaining energy, vitality and a greater sense of well-being.
This is very sad since subclinical hypothyroidism is EPIDEMIC in our toxic world. Just consider the levels of Fluoride and Bromide present today that induce iodine deficiency in our population, as one cause of suboptimal thyroid function. For many other causes please consider owning the new text on Nutritional Medicine by Dr. Alan Gaby with nearly 30,000 references behind it.
We should err on the side of more thyroid support for patients since there are so many contributors to low thyroid function, instead of putting doctors (and their patients) in harm’s way for practicing real medicine.
Kim CH, Ahn JW, Kang SP, Kim SH, Chae HD, Kang BM.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, South Korea.
OBJECTIVE: To investigate whether levothyroxine (LT4) treatment has beneficial effects on IVF results and pregnancy outcome in infertile patients with subclinical hypothyroidism undergoing IVF/intracytoplasmic sperm injection (ICSI).
PATIENT(S): A total of 64 infertile patients with subclinical hypothyroidism, defined as an elevated serum TSH level associated with a normal free T4 level and without frank symptoms of hypothyroidism.
INTERVENTION(S): Patients were randomized into an LT4 treatment group or control group. For the LT4 treatment group, 50 μg LT4 was administered from the first day of controlled ovarian stimulation for IVF/ICSI.
MAIN OUTCOME MEASURE(S): Results of IVF and pregnancy outcome.
RESULT(S): There were no differences in patient characteristics between the two groups. Total dose and days of recombinant human FSH used for controlled ovarian stimulation were also similar. The number of grade I or II embryos was significantly higher in the LT4 treatment group than in the control group. There was no significant difference in the clinical pregnancy rate per cycle between the two groups. However, the miscarriage rate was significantly lower in the LT4 treatment group than in the control group. Embryo implantation rate and live birth rate were significantly higher in the LT4 treatment group. In the control group, both thyroid peroxidase antibody and thyroglobulin antibody levels were significantly higher in the miscarried subgroup than in the delivered subgroup.
CONCLUSION(S): LT4 treatment can improve embryo quality and pregnancy outcome in subclinical hypothyroid women undergoing IVF/ICSI.